Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to GENDER & SEXUALITY

Conexiant

Is 40 the Peak for Men’s Sex Drive?

Endocrinology, Diabetes, Metabolism February 4th 2026

The Journal of Sexual Medicine

Examining Gender-specific Mental Health Risks After Gender-affirming Surgery: A National Database Study

Endocrinology, Diabetes, Metabolism March 13th 2025

MDLinx

Nebraska Woman is Suing for Malpractice After Receiving Gender-affirming Care and Double Mastectomy

All Specialties October 4th 2023

Pharmacy Today

Pharmacists Can Break Down Barriers to Transgender Health Care

Clinical Pharmacology July 31st 2023

General Psychiatry (GPSYCH)

The Mean Age of Gender Dysphoria Diagnosis is Decreasing

Pediatrics July 19th 2023

Pharmacy Today

Gender-affirming Care and Pharmacy Practice

Explore a course created to equip pharmacists with the knowledge and abilities to assist patients who identify as transgender or gender nonconforming (TGND). The educational program “Gender-Affirming Care in Pharmacy Practice” is a comprehensive guide for pharmacists to better serve transgender and gender-diverse (TGD) patients. It provides a deep understanding of the terminology related to TGD patient populations, including definitions of gender identity, gender expression, and various gender identities. The program emphasizes the importance of gender-affirming care, which includes social, medical, psychological, and behavioral care that aligns with a person’s gender identity. It also provides guidance on how to communicate inclusively with TGD patients, such as introducing oneself with name and pronouns, asking open-ended questions, and avoiding unnecessary or invasive questions. Furthermore, the program highlights the health disparities faced by TGD individuals seeking gender-affirming care, such as higher levels of unemployment and healthcare discrimination. It also discusses the coverage of gender-affirming care by Medicaid, which varies across states. The program provides detailed information on hormone therapy for TGD patients, including testosterone and estrogen hormone therapy. It discusses the potential side effects, contraindications, and the importance of contraception for patients at risk of becoming pregnant while on testosterone therapy. Lastly, the […]

Clinical Pharmacology May 31st 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form